X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Nath Bio-Genes (India) Ltd.
BSE CODE: 537291   |   NSE CODE: NATHBIOGEN   |   ISIN CODE : INE448G01010   |   22-Nov-2024 Hrs IST
BSE NSE
Rs. 173.75
1.7 ( 0.99% )
 
Prev Close ( Rs.)
172.05
Open ( Rs.)
180.00
 
High ( Rs.)
180.00
Low ( Rs.)
172.30
 
Volume
565
Week Avg.Volume
3792
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 173.62
1.27 ( 0.74% )
 
Prev Close ( Rs.)
172.35
Open ( Rs.)
175.41
 
High ( Rs.)
179.90
Low ( Rs.)
171.48
 
Volume
9464
Week Avg.Volume
15437
 
52 WK High-Low Range(Rs.)
167.15
264.31
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)21.14  18.50  -35.43  29.29  26.56  
   CEPS(Rs)22.86  20.09  -33.81  30.77  27.33  
   DPS(Rs)2.00  2.00  2.00  2.00  0.00  
   Book NAV/Share(Rs)321.33  301.70  285.19  322.71  293.42  
   Tax Rate(%)4.62  3.17  -6.23  1.92  -4.07  
Margin Ratios          
   Core EBITDA Margin(%)15.17  16.31  13.39  21.71  19.58  
   EBIT Margin(%)15.43  15.49  -18.95  21.33  19.71  
   Pre Tax Margin(%)12.66  12.05  -22.77  18.45  17.33  
   PAT Margin (%)12.08  11.67  -24.19  18.10  18.04  
   Cash Profit Margin (%)13.06  12.67  -23.08  19.01  18.56  
Performance Ratios          
   ROA(%)4.81  4.59  -8.81  7.33  7.33  
   ROE(%)6.79  6.31  -11.66  9.51  9.48  
   ROCE(%)7.34  7.11  -7.82  9.78  9.24  
   Asset Turnover(x)0.40  0.39  0.36  0.41  0.41  
   Sales/Fixed Asset(x)1.22  1.12  1.04  1.16  1.09  
   Working Capital/Sales(x)1.08  0.99  1.02  0.85  0.92  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.82  0.89  0.96  0.87  0.92  
   Receivable days105.14  110.76  127.81  128.40  140.20  
   Inventory Days239.72  259.37  292.83  255.51  234.52  
   Payable days-1432.06  744.29  1663.14  -1472.04  -528.37  
Valuation Parameters          
   PER(x)8.22  7.66  0.00  10.24  5.12  
   PCE(x)7.60  7.05  -6.31  9.75  4.98  
   Price/Book(x)0.54  0.47  0.75  0.93  0.46  
   Yield(%)1.15  1.41  0.94  0.67  0.00  
   EV/Net Sales(x)1.09  1.12  1.78  2.09  1.10  
   EV/Core EBITDA(x)7.10  6.77  12.63  9.37  5.42  
   EV/EBIT(x)7.07  7.21  -9.37  9.78  5.56  
   EV/CE(x)0.50  0.50  0.67  0.81  0.42  
   M Cap / Sales0.99  0.89  1.46  1.85  0.92  
Growth Ratio          
   Net Sales Growth(%)10.40  8.24  -9.49  9.89  21.20  
   Core EBITDA Growth(%)2.90  27.00  -42.83  20.87  24.05  
   EBIT Growth(%)9.94  188.50  -180.38  18.95  24.82  
   PAT Growth(%)14.25  152.22  -220.98  10.26  31.35  
   EPS Growth(%)14.25  152.22  -220.98  10.26  31.35  
Financial Stability Ratios          
   Total Debt/Equity(x)0.18  0.18  0.17  0.16  0.13  
   Current Ratio(x)2.18  2.40  2.41  3.10  2.78  
   Quick Ratio(x)1.30  1.44  1.27  1.79  1.58  
   Interest Cover(x)5.58  4.51  -4.96  7.40  8.29  
   Total Debt/Mcap(x)0.33  0.39  0.23  0.18  0.27